298 related articles for article (PubMed ID: 21681094)
1. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Strati P; Caligaris-Cappio F
Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune complications of chronic lymphocytic leukemia.
Hamblin TJ
Semin Oncol; 2006 Apr; 33(2):230-9. PubMed ID: 16616070
[TBL] [Abstract][Full Text] [Related]
3. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
5. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in chronic lymphocytic leukemia.
Jaglowski SM; Byrd JC
Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
[TBL] [Abstract][Full Text] [Related]
8. Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia.
Jønsson V; Svendsen B; Vorstrup S; Krarup C; Schmalbruch H; Thomsen K; Heegaard NH; Wiik A; Hansen MM
Leukemia; 1996 Feb; 10(2):327-32. PubMed ID: 8637242
[TBL] [Abstract][Full Text] [Related]
9. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
10. CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia.
Citores MJ; Castejon R; Villarreal M; Rosado S; Garcia-Marco JA; Vargas JA
Exp Hematol; 2010 Mar; 38(3):165-73. PubMed ID: 20026377
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
Molica S
Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders.
Duek A; Shvidel L; Braester A; Berrebi A
Isr Med Assoc J; 2006 Dec; 8(12):828-31. PubMed ID: 17214095
[TBL] [Abstract][Full Text] [Related]
13. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia.
Keating MJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):107-14. PubMed ID: 10561025
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL.
Klepfish A; Gilles L; Ioannis K; Rachmilewitz EA; Schattner A
Ann N Y Acad Sci; 2009 Sep; 1173():865-73. PubMed ID: 19758239
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
18. Beyond detectable minimal residual disease in chronic lymphocytic leukemia.
Hillmen P
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S23-8. PubMed ID: 16720200
[TBL] [Abstract][Full Text] [Related]
19. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia.
Barcellini W; Capalbo S; Agostinelli RM; Mauro FR; Ambrosetti A; Calori R; Cortelezzi A; Laurenti L; Pogliani EM; Pedotti P; Liso V; Girelli G; Mandelli F; Zanella A;
Haematologica; 2006 Dec; 91(12):1689-92. PubMed ID: 17145607
[TBL] [Abstract][Full Text] [Related]
20. Broad alterations of self-reactive antibody-repertoires of plasma IgM and IgG in B-cell chronic lymphocytic leukemia (B-CLL) and B-CLL related target-restricted autoimmunity.
Stahl D; Lacroix-Desmazes S; Sibrowski W; Kazatchkine MD; Kaveri SV
Leuk Lymphoma; 2001 Jun; 42(1-2):163-76. PubMed ID: 11699204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
